These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4564549)

  • 1. [Treatment of primitive hyperlipidemias with a tetralin derivative].
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    G Ital Cardiol; 1972; 2(6):863-70. PubMed ID: 4564549
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.
    Camarri E; Fici F; Marcolongo R
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    Atherosclerosis; 1973; 17(3):383-8. PubMed ID: 4577009
    [No Abstract]   [Full Text] [Related]  

  • 8. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

  • 9. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G; Keller C; Kilani C; Zöllner N
    Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration.
    Camarri E; Marcolongo R; Fici F
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):527-8. PubMed ID: 365797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of activated charcoal on hyperlipidaemia. A double-blind prospective trial.
    Hoekstra JB; Erkelens DW
    Neth J Med; 1988 Dec; 33(5-6):209-16. PubMed ID: 3065658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with etiroxate hydrochloride in patients with primary hyperlipoproteinemia].
    Knüchel F
    Med Welt; 1977 Jan; 28(4):186-9. PubMed ID: 320426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
    Agusti R; Jordán C; Aste H; Tapia F
    Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tiadenol in the treatment of primary hyperlipidemias].
    Liguori A; Sibilio G; Mastursi M; Tarzia R; Casale A; Pellegrino G; Varriale A
    G Clin Med; 1981 Jan; 62(1):51-64. PubMed ID: 7227710
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acipimox treatment of hyperlipidemia type II].
    Noseda G; Fragiacomo C; Cairoli R
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1790-1. PubMed ID: 6758114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 18. Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Studies in patients with types II-A and II-B.
    Barter PJ; Connor WE; Spector AA; Armstrong M; Connor SL; Newman MA
    Ann Intern Med; 1974 Nov; 81(5):619-24. PubMed ID: 4609028
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid profiles.
    Winder T
    Br J Hosp Med; 1994 Feb 2-15; 51(3):102-4. PubMed ID: 8193830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of oxandrolone in hyperlipidaemia.
    Doyle AE; Pinkus NB; Green J
    Med J Aust; 1974 Feb; 1(5):127-9. PubMed ID: 4594252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.